IMR Press / RCM / Volume 3 / Issue S3 / pii/1561516738545-1407314776

Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with MedReviews, LLC.

Open Access Review
Special Clinical Considerations of Beta-Blocker Treatment
Show Less
1 Departments of Medicine and Cardiology, Heart Failure/Transplantation Services, University of Texas Southwestern Medical Center, Dallas, TX
Rev. Cardiovasc. Med. 2002, 3(S3), 27–35;
Published: 20 May 2002
Abstract
Outcomes for heart failure have improved considerably with the implementation of neurohormonal antagonism that includes angiotensin-converting enzyme inhibitors and ß-blockers. Despite the robust benefit of ß-blockers for heart failure, it is not clear that the benefit can be extended to all patient groups. Special clinical consideration thus needs to be given to the elderly, women, and African Americans. A retrospective review of available data suggests that despite differences in the natural history of heart failure for these groups, significant benefit can still be expected from the use of ß-blockers for heart failure. Future trials will address these groups in a prospective manner.  
Keywords
Heart failure
Special populations
African Americans
Elderly
Women
Betablockers
Share
Back to top